UBS O'Connor’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,000	Closed	-$641K	–	432
2023 Q3	$641K	Sell	35,000 -4,000	-10%	-$73.2K	0.01%	361
2023 Q2	$841K	Buy	+39,000	New	+$841K	0.02%	394